niclosamide has been researched along with ALS - Amyotrophic Lateral Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Andjus, P; Apolloni, S; Carrì, MT; Cozzolino, M; D'Ambrosi, N; Lattante, S; Michetti, F; Peric, M; Rossi, S; Sabatelli, M; Serrano, A | 1 |
| Apolloni, S; Cozzolino, M; D'Ambrosi, N; Lattante, S; Mammarella, E; Miele, C; Milani, M; Rossi, S; Sabatelli, M | 1 |
| Kato, Y; Sakamoto, K | 1 |
3 other study(ies) available for niclosamide and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis.
Topics: Adult; Amyotrophic Lateral Sclerosis; Animals; Blotting, Western; Cell Movement; Cells, Cultured; Electrophoresis, Polyacrylamide Gel; Female; Fibroblasts; Humans; Male; Mice; Microglia; Microscopy, Fluorescence; Middle Aged; NF-kappa B; Niclosamide; Phagocytosis; Real-Time Polymerase Chain Reaction; S100 Calcium-Binding Protein A4; Superoxide Dismutase-1; TOR Serine-Threonine Kinases | 2019 |
Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Disease Models, Animal; Fibroblasts; Fibrosis; Humans; Inflammation; Mice; Mutation; NF-kappa B; Niclosamide; RNA-Binding Protein FUS; S100 Calcium-Binding Protein A4; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Niclosamide affects intracellular TDP-43 distribution in motor neurons, activates mitophagy, and attenuates morphological changes under stress.
Topics: Amyotrophic Lateral Sclerosis; DNA-Binding Proteins; Humans; Mitophagy; Motor Neurons; Niclosamide | 2021 |